We are attending ELRIG UK’s Label-Free Mass Spectrometry Assays for Early Drug Discovery, 25th January. The symposium will bring together leading academic and industry experts to reflect on the opportunities and challenges to accelerate the discovery of novel starting points using state-of-the-art MS-based screening methods.
- Cell-based MALDI MS assays for the characterization of enzymatic reactions and transporter uptake
- Unbiased high-throughput MALDI-TOF MS screening assays in primary human cells for drug discovery
- Evaluating target engagement of drug-like and pan-assay interfering compounds using ASMS
Register here to join us.